phenazopyridine has been researched along with Ureteral Obstruction in 2 studies
Phenazopyridine: A local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
phenazopyridine : A diaminopyridine that is 2,6-diaminopyridine substituted at position 3 by a phenylazo group. A local anesthetic that has topical analgesic effect on mucosa lining of the urinary tract. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.
Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three ureteral obstructions were identified intraoperatively and none in the postoperative period." | 2.82 | Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial. ( Alas, AN; Barber, M; Chadi, SA; Davila, GW; Espaillat-Rijo, L; Hurtado, EA; Siff, L; Vaish, S; Zimberg, S, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askew, AL | 1 |
| Myers, ER | 1 |
| Dieter, AA | 1 |
| Espaillat-Rijo, L | 1 |
| Siff, L | 1 |
| Alas, AN | 1 |
| Chadi, SA | 1 |
| Zimberg, S | 1 |
| Vaish, S | 1 |
| Davila, GW | 1 |
| Barber, M | 1 |
| Hurtado, EA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Perioperative Administration of Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery[NCT03524339] | Phase 2/Phase 3 | 132 participants (Actual) | Interventional | 2018-08-01 | Completed | ||
| Evaluation of Ureteral Jets on Cystoscopy: A Randomized Controlled Trial[NCT02476448] | 176 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy[NCT05190939] | 276 participants (Actual) | Interventional | 2018-07-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Total and subscale scores reported. Total score range 0-35, with 0 being less symptomatic and 35 being more symptomatic. Total score is sum of individual questions. Seven subgroups address incomplete bladder emptying, frequency, intermittency, urgency, weak stream, straining, nocturia. Each subgroup is scored 0-5 with 5 being most symptomatic. The last question is independent, rates quality of life from 0 (best) to 6 (worst) (NCT03524339)
Timeframe: Within 1 week of surgery
| Intervention | Points (Median) |
|---|---|
| Placebo | 6 |
| Tamsulosin | 7 |
Failed voiding trial upon removal of catheter (NCT03524339)
Timeframe: Within 72 hours of surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 16 |
| Tamsulosin | 5 |
Treated for urinary tract infection with antibiotics or urinalysis or urine culture suggests infection. (NCT03524339)
Timeframe: Within 6 weeks after surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 6 |
| Tamsulosin | 4 |
Urinary retention that required homegoing catheterization (NCT03524339)
Timeframe: within 6 weeks of surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Placebo | 7 |
| Tamsulosin | 5 |
Medical records will be followed prospectively for 6 weeks to assess for incidence of urinary tract infections within different groups. (NCT02476448)
Timeframe: 6 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Normal Saline | 10 |
| Dextrose 10% | 13 |
| Phenazopyridine | 9 |
| Sodium Fluorescein | 10 |
1 trial available for phenazopyridine and Ureteral Obstruction
| Article | Year |
|---|---|
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
Intraoperative Cystoscopic Evaluation of Ureteral Patency: A Randomized Controlled Trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Attitude of Health Personnel; Cystoscopy; F | 2016 |
1 other study available for phenazopyridine and Ureteral Obstruction
| Article | Year |
|---|---|
Cost-effectiveness of agents used for evaluation of ureteral patency during intraoperative cystoscopy in gynecologic and urogynecologic surgery.
Topics: Coloring Agents; Cost-Benefit Analysis; Cystoscopy; Female; Fluorescein; Gynecologic Surgical Proced | 2022 |